Profile photo Joost Swart

Joost Swart

Associate Professor - medical

Strategic program(s):

Biography

Joost Swart is a board certified paediatrician immunologist & rheumatologist. After receiving his Medical Degree (cum laude/ with Honour) from the University of Groningen in 1999, he finished his training as a paediatrician at the VU Medical Center in Amsterdam in 2006. His fellowship paediatric rheumatology-immunology was completed in 2008 in Utrecht. He worked as a paediatric rheumatologist for 3 years in both Reade and the VUmc in Amsterdam. In 2011 he came to work in the largest Dutch group of Pediatric Rheumatology / Immunology based in Utrecht. He is currently doing a Master in Epidemiology at Utrecht University.

His research (and that of his PhD-students) focuses on comparative effectiveness and safety of drugs, treatment-strategies and eHealth in juvenile idiopathic arthritis (JIA). He also analysed the effects of mesenchymal stem cells in JIA-patients. Furthermore he is researcher and member of the Steering Committee of the international Pharmacovigilance database Pharmachild (over 9000 JIA-patients who have contributed their clinical data and thousands of blood and synovial samples) and is co-P.I. of the UCAN CAN-DU project (JIA project involving all academic paediatric rheumatology centers in the Netherlands and Canada). https://www.ucancandu.com/

He is (co-)author on more than 60 scientific articles in peer-reviewed journals, mostly related to JIA. He is (co-)applicant on multiple successful research grants (e.g. UCAN CAN-DU. Real-life integration of innovative precision medicine strategies into care provision will forever transform the care of children with arthritis in our countries and beyond. Canadian Institutes of Health Research/ The Netherlands Organisation for Health Research and Development [ZonMw]/ Dutch Arthritis Foundation funded  €5,500,000).

He is council member of the Dutch Association for Paediatric Rheumatology, council member of the Pediatric Rheumatology International Trial Organization and chair of the Pharmacovigilance and Targeted Therapies Working Party of ERN-RITA. He is member of the Dutch Pediatric Association, Dutch Rheumatology Association, Paediatric Rheumatology European Society, and the Dutch Association against Quackery.

He educates students in both the CRU and Summa medical curricula in Utrecht. He trains interns, residents and fellows in paediatrics and rheumatology in UMC Utrecht. He is a certified instructor on the APLS-course from the Advance Life Support Group.

Recent publications

Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay Julia E Möhlmann, Sytze de Roock, Annelies C Egas, Evelien Ter Weijden, Martijn J H Doeleman, Alwin D R Huitema, Matthijs van Luin, Joost F Swart
Pediatric rheumatology online journal, 2024, vol. 22
Enhanced aortic stiffness in adolescents with chronic disease is associated with decreased left ventricular global longitudinal strain Victor A Verpalen, Francesca A Ververs, Martijn Slieker, Roos Nuboer, Joost F Swart, Cornelis K van der Ent, Zina Fejzic, Jos J M Westenberg, Tim Leiner, Heynric B Grotenhuis, Henk S Schipper
IJC Heart and Vasculature, 2024, vol. 52
Humoral and cellular immunogenicity, effectiveness and safety of COVID-19 mRNA vaccination in patients with pediatric rheumatic diseases Mohamad Hamad Saied, Joeri W van Straalen, Sytze de Roock, Frans M Verduyn Lunel, Jelle de Wit, Lia G H de Rond, Erika Van Nieuwenhove, Bas J Vastert, Joris M van Montfrans, Annet van Royen-Kerkhof, Gerrie C J de Joode-Smink, Joost F Swart, Nico M Wulffraat, Marc H A Jansen
Vaccine, 2024, vol. 42, p.1145-1153
Managing juvenile idiopathic arthritis within the context of their life G. R. Currie, B. L. Kennedy, S. M. Benseler, Yeung R. S. M., J. F. Swart, S. J. Vastert, N. M. Wulffraat, Kip M. M. A., Gail MacKean, D. A. Marshall
Musculoskeletal Care, 2023, vol. 21, p.1248-1260
Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis Arjan Boltjes, Anoushka Ashok Kumar Samat, Maud Plantinga, Michal Mokry, Bas Castelijns, Joost F. Swart, Sebastiaan J. Vastert, Menno Creyghton, Stefan Nierkens, Jorg van Loosdregt, Femke van Wijk
Frontiers in Immunology, 2023, vol. 13
The clinical and experimental treatment of Juvenile Idiopathic Arthritis L Nijhuis, J F Swart, B J Prakken, J V Loosdregt, S J Vastert
Clinical and Experimental Immunology, 2023, vol. 213, p.276-287

Fellowships & Awards

2016: Kourir Award 2016

2015: EULAR Honeurs

2014: Pfizer Aspire Grant Winner: Award Use of JADAS for future treat-to-target therapy in JIA